Annual Interest Expense
$395.00 K
-$316.00 K-44.44%
01 December 2023
Summary:
Plus Therapeutics annual interest expense is currently $395.00 thousand, with the most recent change of -$316.00 thousand (-44.44%) on 01 December 2023. During the last 3 years, it has fallen by -$712.00 thousand (-64.32%). PSTV annual interest expense is now -90.96% below its all-time high of $4.37 million, reached on 31 December 2014.PSTV Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Interest Expense
$61.00 K
-$3.51 M-98.29%
01 September 2024
Summary:
Plus Therapeutics quarterly interest expense is currently $61.00 thousand, with the most recent change of -$3.51 million (-98.29%) on 01 September 2024. Over the past year, it has dropped by -$1000.00 (-1.61%). PSTV quarterly interest expense is now -98.29% below its all-time high of $3.57 million, reached on 01 June 2024.PSTV Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Interest Expense
$3.73 M
-$26.00 K-0.69%
01 September 2024
Summary:
Plus Therapeutics TTM interest expense is currently $3.73 million, with the most recent change of -$26.00 thousand (-0.69%) on 01 September 2024. Over the past year, it has increased by +$3.33 million (+844.05%). PSTV TTM interest expense is now -17.17% below its all-time high of $4.50 million, reached on 31 March 2015.PSTV TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PSTV Interest Expense Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | - | -1.6% | +844.0% |
3 y3 years | -64.3% | -73.7% | +288.0% |
5 y5 years | -79.5% | -83.3% | +84.5% |
PSTV Interest Expense High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -64.3% | at low | -98.3% | +79.4% | -0.7% | +1164.1% |
5 y | 5 years | -79.5% | at low | -98.3% | +79.4% | -0.7% | +1164.1% |
alltime | all time | -91.0% | at low | -98.3% | +79.4% | -17.2% | +1164.1% |
Plus Therapeutics Interest Expense History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $61.00 K(-98.3%) | $3.73 M(-0.7%) |
June 2024 | - | $3.57 M(>+9900.0%) | $3.75 M(+1172.9%) |
Mar 2024 | - | $34.00 K(-45.2%) | $295.00 K(-25.3%) |
Dec 2023 | $395.00 K(-44.4%) | $62.00 K(-28.7%) | $395.00 K(-19.7%) |
Sept 2023 | - | $87.00 K(-22.3%) | $492.00 K(-14.9%) |
June 2023 | - | $112.00 K(-16.4%) | $578.00 K(-10.7%) |
Mar 2023 | - | $134.00 K(-15.7%) | $647.00 K(-9.0%) |
Dec 2022 | $711.00 K(-23.7%) | $159.00 K(-8.1%) | $711.00 K(-8.4%) |
Sept 2022 | - | $173.00 K(-4.4%) | $776.00 K(-7.1%) |
June 2022 | - | $181.00 K(-8.6%) | $835.00 K(-5.4%) |
Mar 2022 | - | $198.00 K(-11.6%) | $883.00 K(-5.3%) |
Dec 2021 | $932.00 K(-15.8%) | $224.00 K(-3.4%) | $932.00 K(-3.0%) |
Sept 2021 | - | $232.00 K(+1.3%) | $961.00 K(-2.1%) |
June 2021 | - | $229.00 K(-7.3%) | $982.00 K(-2.3%) |
Mar 2021 | - | $247.00 K(-2.4%) | $1.00 M(-9.2%) |
Dec 2020 | $1.11 M(-40.3%) | $253.00 K(0.0%) | $1.11 M(-10.1%) |
Sept 2020 | - | $253.00 K(+0.4%) | $1.23 M(-8.4%) |
June 2020 | - | $252.00 K(-27.8%) | $1.34 M(-20.4%) |
Mar 2020 | - | $349.00 K(-7.7%) | $1.69 M(-8.9%) |
Dec 2019 | $1.85 M(-3.5%) | $378.00 K(+3.3%) | $1.86 M(-8.2%) |
Sept 2019 | - | $366.00 K(-38.7%) | $2.02 M(-6.8%) |
June 2019 | - | $597.00 K(+15.9%) | $2.17 M(+7.6%) |
Mar 2019 | - | $515.00 K(-5.2%) | $2.02 M(+4.8%) |
Dec 2018 | $1.92 M(-6.2%) | $543.00 K(+5.8%) | $1.92 M(+5.3%) |
Sept 2018 | - | $513.00 K(+15.5%) | $1.83 M(+2.2%) |
June 2018 | - | $444.00 K(+5.0%) | $1.79 M(-5.0%) |
Mar 2018 | - | $423.00 K(-5.2%) | $1.88 M(-8.2%) |
Dec 2017 | $2.05 M(-20.9%) | $446.00 K(-5.9%) | $2.05 M(-8.9%) |
Sept 2017 | - | $474.00 K(-11.9%) | $2.25 M(-7.1%) |
June 2017 | - | $538.00 K(-9.0%) | $2.42 M(-4.2%) |
Mar 2017 | - | $591.00 K(-8.4%) | $2.53 M(-2.5%) |
Dec 2016 | $2.59 M | $645.00 K(0.0%) | $2.59 M(-2.2%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2016 | - | $645.00 K(0.0%) | $2.65 M(-0.9%) |
June 2016 | - | $645.00 K(-1.8%) | $2.67 M(-9.8%) |
Mar 2016 | - | $657.00 K(-6.4%) | $2.96 M(-12.3%) |
Dec 2015 | $3.38 M(-22.7%) | $702.00 K(+4.9%) | $3.38 M(-10.2%) |
Sept 2015 | - | $669.00 K(-28.5%) | $3.76 M(-13.6%) |
June 2015 | - | $936.00 K(-12.7%) | $4.35 M(-3.3%) |
Mar 2015 | - | $1.07 M(-1.2%) | $4.50 M(+3.0%) |
Dec 2014 | $4.37 M(+28.7%) | $1.08 M(-13.9%) | $4.37 M(+3.4%) |
Sept 2014 | - | $1.26 M(+16.1%) | $4.23 M(+4.1%) |
June 2014 | - | $1.08 M(+15.3%) | $4.06 M(+11.9%) |
Mar 2014 | - | $941.00 K(+0.1%) | $3.63 M(+6.8%) |
Dec 2013 | $3.40 M(+0.3%) | $940.00 K(-14.1%) | $3.40 M(+4.2%) |
Sept 2013 | - | $1.09 M(+67.8%) | $3.26 M(+7.8%) |
June 2013 | - | $652.00 K(-8.0%) | $3.02 M(-6.4%) |
Mar 2013 | - | $709.00 K(-11.8%) | $3.23 M(-4.6%) |
Dec 2012 | $3.39 M(+21.6%) | $804.00 K(-6.2%) | $3.39 M(-1.7%) |
Sept 2012 | - | $857.00 K(-0.3%) | $3.44 M(+12.0%) |
June 2012 | - | $860.00 K(-0.6%) | $3.08 M(+5.6%) |
Mar 2012 | - | $865.00 K(+0.5%) | $2.91 M(+4.6%) |
Dec 2011 | $2.78 M(+35.7%) | $861.00 K(+76.1%) | $2.78 M(+3.6%) |
Sept 2011 | - | $489.00 K(-29.7%) | $2.69 M(-9.1%) |
June 2011 | - | $696.00 K(-5.7%) | $2.96 M(+17.6%) |
Mar 2011 | - | $738.00 K(-3.4%) | $2.52 M(+22.5%) |
Dec 2010 | $2.05 M(+43.8%) | $764.00 K(+0.7%) | $2.05 M(+28.6%) |
Sept 2010 | - | $759.00 K(+198.8%) | $1.60 M(+34.9%) |
June 2010 | - | $254.00 K(-8.0%) | $1.18 M(-9.2%) |
Mar 2010 | - | $276.00 K(-10.1%) | $1.30 M(-8.7%) |
Dec 2009 | $1.43 M(+239.8%) | $307.00 K(-11.3%) | $1.43 M(+27.4%) |
Sept 2009 | - | $346.00 K(-7.5%) | $1.12 M(+44.7%) |
June 2009 | - | $374.00 K(-6.5%) | $774.00 K(+93.5%) |
Mar 2009 | - | $400.00 K | $400.00 K |
Dec 2008 | $420.00 K | - | - |
FAQ
- What is Plus Therapeutics annual interest expense?
- What is the all time high annual interest expense for Plus Therapeutics?
- What is Plus Therapeutics quarterly interest expense?
- What is the all time high quarterly interest expense for Plus Therapeutics?
- What is Plus Therapeutics quarterly interest expense year-on-year change?
- What is Plus Therapeutics TTM interest expense?
- What is the all time high TTM interest expense for Plus Therapeutics?
- What is Plus Therapeutics TTM interest expense year-on-year change?
What is Plus Therapeutics annual interest expense?
The current annual interest expense of PSTV is $395.00 K
What is the all time high annual interest expense for Plus Therapeutics?
Plus Therapeutics all-time high annual interest expense is $4.37 M
What is Plus Therapeutics quarterly interest expense?
The current quarterly interest expense of PSTV is $61.00 K
What is the all time high quarterly interest expense for Plus Therapeutics?
Plus Therapeutics all-time high quarterly interest expense is $3.57 M
What is Plus Therapeutics quarterly interest expense year-on-year change?
Over the past year, PSTV quarterly interest expense has changed by -$1000.00 (-1.61%)
What is Plus Therapeutics TTM interest expense?
The current TTM interest expense of PSTV is $3.73 M
What is the all time high TTM interest expense for Plus Therapeutics?
Plus Therapeutics all-time high TTM interest expense is $4.50 M
What is Plus Therapeutics TTM interest expense year-on-year change?
Over the past year, PSTV TTM interest expense has changed by +$3.33 M (+844.05%)